Medivolve Inc
Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.
Medivolve Inc (MEDVF) - Total Assets
Latest total assets as of March 2024: $1.76 Million USD
Based on the latest financial reports, Medivolve Inc (MEDVF) holds total assets worth $1.76 Million USD as of March 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medivolve Inc - Total Assets Trend (2006–2023)
This chart illustrates how Medivolve Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medivolve Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Medivolve Inc's total assets of $1.76 Million consist of 62.0% current assets and 38.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 34.1% |
| Accounts Receivable | $262.13K | 11.1% |
| Inventory | $38.26K | 1.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $100.23K | 4.2% |
| Goodwill | $394.83K | 16.7% |
Asset Composition Trend (2006–2023)
This chart illustrates how Medivolve Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medivolve Inc's current assets represent 62.0% of total assets in 2023, an increase from 26.0% in 2006.
- Cash Position: Cash and equivalents constituted 34.1% of total assets in 2023, up from 0.9% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 16.7% of total assets.
Medivolve Inc Competitors by Total Assets
Key competitors of Medivolve Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.47 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Medivolve Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Medivolve Inc generates 0.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Medivolve Inc is currently not profitable relative to its asset base.
Medivolve Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.05 | 0.79 | 45.75 |
| Quick Ratio | 0.05 | 0.79 | 47.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-18.04 Million | $ -3.18 Million | $ 3.18 Million |
Medivolve Inc - Advanced Valuation Insights
This section examines the relationship between Medivolve Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.73 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -87.4% |
| Total Assets | $2.37 Million |
| Market Capitalization | $54.04K USD |
Valuation Analysis
Below Book Valuation: The market values Medivolve Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Medivolve Inc's assets decreased by 87.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Medivolve Inc (2006–2023)
The table below shows the annual total assets of Medivolve Inc from 2006 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $2.37 Million | -87.42% |
| 2022-12-31 | $18.82 Million | -68.26% |
| 2021-12-31 | $59.30 Million | +209.94% |
| 2020-12-31 | $19.13 Million | +731.62% |
| 2019-12-31 | $2.30 Million | -49.78% |
| 2018-12-31 | $4.58 Million | -13.53% |
| 2017-12-31 | $5.30 Million | +138.51% |
| 2016-12-31 | $2.22 Million | +133.13% |
| 2015-12-31 | $952.78K | -26.46% |
| 2014-12-31 | $1.30 Million | -70.98% |
| 2013-12-31 | $4.46 Million | -58.56% |
| 2012-12-31 | $10.77 Million | -19.06% |
| 2011-12-31 | $13.31 Million | +88.23% |
| 2010-12-31 | $7.07 Million | -14.27% |
| 2009-12-31 | $8.25 Million | +293.75% |
| 2008-12-31 | $2.09 Million | +430.27% |
| 2007-12-31 | $395.02K | +2297.38% |
| 2006-12-31 | $16.48K | -- |